Connect with us
  • Elysium


Daily News Roundup: Monday, 29 April



Welcome to your daily round-up of everything happening in the world of neurorehabilitation.

Research news

Robotic nerve ‘cuffs’ could help treat a range of neurological conditions

Researchers have developed tiny, flexible devices that can wrap around individual nerve fibres without damaging them. The researchers, from the University of Cambridge, combined flexible electronics and soft robotics techniques to develop the devices, which could be used for the diagnosis and treatment of a range of disorders, including epilepsy and chronic pain, or the control of prosthetic limbs.

Gene linked to epilepsy, autism decoded in new study

A genetic change or variant in a gene called SCN2A is a known cause of infantile seizures, autism spectrum disorder and intellectual disability, as well as a wide range of other moderate-to-profound impairments in mobility, communication, eating and vision.  The severity of these disorders can vary widely from person to person, but little is known about what is happening at the level of the SCN2A protein to cause these differences.   A new Northwestern Medicine study helps explain how changes in the SCN2A gene affect whether or not a child will develop autism or epilepsy, the age at which seizures start for those with epilepsy and the severity of the child’s other impairments.

Children with symptoms of brain injuries and concussions are missing out on vital checks

Almost a quarter of US children with symptoms of a brain injury or concussion are not checked for the condition, with younger children particularly likely to be overlooked, a new national study finds. The peer-reviewed US research, which is published in the journal Brain Injury, also shows that children with symptoms or a diagnosis of a brain injury or concussion were more likely to have symptoms of depression than other youngsters. They also found it harder to make friends.

Company and financial neuro-rehab news

Multiple Sclerosis patients receiving intranasal Foralumab

Tiziana Life Sciences, a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announced for the first time, quantitative data showing improvement in White Matter Z-scores measured from PET images taken at 3 months in nasal foralumab treated patients with non-active secondary progressive multiple sclerosis (na-SPMS). White Matter Z-scores are a statistical measure used in neuroimaging studies to assess the integrity or abnormalities in structures of the brain.

Technology news

Using AI to improve diagnosis of Rare Genetic Disorders

Diagnosing rare Mendelian disorders is a labor-intensive task, even for experienced geneticists. Investigators at Baylor College of Medicine are trying to make the process more efficient using artificial intelligence. The team developed a machine learning system called AI-MARRVEL (AIM) to help prioritise potentially causative variants for Mendelian disorders. The study is published today in NEJM AI.

Science ministers commit to better forecast and steer disruptive new technologies

Science ministers from across the world have endorsed a new approach to how new technologies are regulated, warning that governments need to foresee and steer breakthroughs, rather than being caught on the back foot and reacting to problems after they emerge. Spooked by sudden advances in artificial intelligence (AI), they endorsed a new set of ideas drawn up by the Organisation for Economic Co-operation and Development (OECD) in a get-together this week in Paris.